SCHEMBL16615268

SCHEMBL16615268

O=C(Nc1cccc(C(=O)N2CCNCC2)c1)c1c2c3c(n1-2)NCCN3Cc1cc(Cl)ccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41
EPHX2 P34913 1/20 0.40
CCNC P24863 8/20 0.40
CDK8 P49336 8/20 0.40
RAB9A P51151 1/20 0.39
GABRD O14764 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB1 P18505 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
GABRB2 P47870 2/20 0.38
GABRA4 P48169 2/20 0.38
CBLB Q13191 1/20 0.37
ATR Q13535 1/20 0.36
TP53 P04637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16615358 0.91 CCNC (0.46) CCNCCDK8
SCHEMBL16615215 0.85 ALK (0.50) KDM4EPOLBHTTEPHX2RAB9A
SCHEMBL16615074 0.83 MAPT (0.45) KDM4EPOLBHTTEPHX2RAB9A
SCHEMBL16615299 0.83 POLB (0.41) POLBEPHX2CCNCCDK8RAB9A
SCHEMBL16615217 0.83 KCNQ2 (0.44) KDM4EPOLBHTTRAB9A
SCHEMBL16615216 0.81 ALK (0.49) CCNCCDK8
SCHEMBL16615102 0.77 MAPT (0.44) KDM4EPOLBHTTRAB9A
SCHEMBL17918786 0.73 ALK (0.46) KDM4EPOLBHTTEPHX2RAB9A
SCHEMBL17918724 0.71 CCNC (0.47) CCNCCDK8
SCHEMBL16615305 0.71 KMT2A (0.40) KDM4EPOLBHTTRAB9AGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015047133-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОТЕЧЕСТВЕННЫЕ ФАРМАЦЕВТИЧЕСКИЕ ТЕХНОЛОГИИ" 2015-04-02 WO disclosed